CHICAGO, Ill. – Gilbane Building Company has commenced construction on the new pharmaceutical manufacturing site expansion for Fresenius Kabi in Melrose Park, Illinois.
The scope of work includes construction of a new $250-million, state-of-the-art manufacturing campus for generic sterile injectable pharmaceuticals. The expansion will feature fully automated aseptic filling lines using state-of-the-art isolator technology, expanded lyophilization (freeze-drying) capabilities, formulation areas, a dedicated warehouse for raw materials and components and an administration building with conference center, laboratories, office space and a cafeteria.
This complex manufacturing facility will be completed utilizing a fast-track, phased design and phased procurement approach to achieve the required construction timeline. The new facility, designed primarily by CRB, is slated for completion in fall 2019.
Join our thriving community of 70,000+ superintendents and trade professionals on LinkedIn!
Search our job board for your next opportunity, or post an opening within your company.
Subscribe to our monthly
Construction Superintendent eNewsletter and stay current. 
